Risk of cardiovascular events following intermittent and continuous androgen deprivation therapy in patients with nonmetastatic prostate cancer
Related Posts
Miyazaki Y, Park YM, Rimmer M, Miyazaki K, Yamagami S, Izawa Y, Osai N, Hanna P, Fishbein MC, Shivkumar K, Mori S. Understanding Cardiac Anatomy[...]
Jafarvand M, Farolfi A, Mei R, Djaileb L, Benz M, Chung A, Brisbane W, Marks L, Grogan T, Gafita A, Theus L, Nguyen AT, Czernin[...]
Mora R, Irannejad K, Abbas N, Mogga P, Iskander B, Hubbard L, Roy S, Lakshmanan S, Budoff M, Krishnan S. Emerging quantitative CCTA imaging biomarkers[...]